Fallon, Zay, Eko, and Bashaun pose in a park.

Fallon Williams, left, pictured with her son, Zay, daughter, Eko, and husband, Bashaun.

February 10, 2025

From the Hole in Her Heart to Whole Heart Health, One ARUP Employee Is Making an Impact

Fallon Williams and her daughter have similar heart conditions, which do not have a known genetic cause. Williams hopes

Gloved hands hold a sample and a laboratory instrument while performing germline testing.

Several ARUP Consult® topics discuss in detail when germline testing for hereditary cancer syndromes should be considered to help clinicians order the right test at the right time.

February 6, 2025

ARUP Consult Highlights Hereditary Cancer Testing Resources During National Cancer Prevention Month…

February is National Cancer Prevention Month. ARUP Consult provides guidance on hereditary

Close up image of a virus

ARUP Consult® has timely resources on influenza viruses, COVID-19, and RSV.

January 13, 2025

ARUP Consult Provides Resources for Clinicians Diagnosing Viral…

ARUP Consult offers expert guidance on laboratory testing for influenza, RSV, and COVID-19,

Bird flu cell

ARUP’s new assay, Influenza A (H5) Virus by Qualitative NAAT (ARUP test number 3018970), will expand the national capacity to detect the current outbreak of highly pathogenic avian influenza A (H5N1).

January 3, 2025

ARUP Offers New Assay To Detect Influenza A (H5) Virus

ARUP has launched a new assay for the detection and subtyping of influenza A (H5) virus, which will expand the national capacity to detect

Benjamin Bradley

Benjamin Bradley, MD, PhD, medical director of the ARUP Institute for Research and Innovation in Infectious Disease Genomic Technologies, High Consequence Pathogen Response, Virology, and Molecular Infectious Diseases, participated in a media briefing on avian influenza.

December 20, 2024

ARUP Medical Director: We Are Monitoring H5N1 (Bird Flu) and Have the Capacity To Detect It

Benjamin Bradley, MD, PhD, compared the H5N1 outbreak to COVID-19, highlighting the preparedness

Peng Li sits in a lab in front of an electronic microscope.

Peng Li, MD, PhD, ARUP medical director, seeks to increase awareness to the newly discovered VEXAS syndrome with a recently published blog and paper.

December 6, 2024

ARUP Medical Director: Next Generation Sequencing Testing Offers Hope to Patients With VEXAS Syndrome…

Next generation sequencing (NGS) testing detects UBA1 gene mutations, which are